Intramuscular Injections of Paliperidone Palmitate in the Arm or Buttock of Subjects With Schizophrenia
Status:
Completed
Trial end date:
2004-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare the pharmacokinetic parameters (blood concentrations)
of i.m. paliperidone palmitate after administration in 2 different injection sites (deltoid
or gluteal).
Phase:
Phase 3
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.